MedCity INVEST unites active healthcare venture capitalists and corporate business development executives with more than 30 of the most promising healthcare startups to facilitate investment opportunities and showcase dealflow. This event, held in association with Mid-America Healthcare Investors Network (MHIN), will take place April 12-13, 2016 in Chicago.
I encourage you to make plans now to join healthcare venture capital and startup communities at MedCity INVEST– the premier event of its kind: a national healthcare investing conference based in the Midwest.
Register by February 2 and you’ll save $400 off the full price. Hurry, this is the best and lowest rate for this event.
For over a decade, this event (formerly MidAmerica Healthcare Venture Forum), has been bringing the latest technology and emerging innovations to the investment community.
Join us April 22-23 to hear from thought leaders, prominent industry players and startup companies spanning the digital health/health IT, diagnostics, medical device, biopharmaceuticals and biotech sectors. You’ll hear from speakers from AbbVie Biotech, Mayo Clinic Ventures, Kaiser Permanente Ventures, McKesson, Arboretum, Takeda, Baxalta and many others.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The program consists of sessions that include: CEOs on IPOs: Managing a Company from Private to Public, Best Practices With Corporate Venture Capital in Digital Health and How Far Away Is a Real Direct-to-Consumer Business Model? There will be a special research presentation on Corporate Venture Capital In Digital Health And Life Sciences and a session focusing on Opportunities in the Midwest.
For the best return on your investment, reserve your place now. For just a few more days you’ll save $400 and get our very best rate. This rate ends February 2.
Who should attend MedCity INVEST?
- C-level executives from healthcare startups
- Venture capitalists, angel investors and investment banker
- Corporate business development executives and R&D officers
- Tech transfer officers, incubators and healthcare consultants
This conference is not to be missed by anyone interested in knowing the trends and up-and-coming startups in healthcare, digital health and the life sciences.
MedCity INVEST will be held April 12-13, 2016 in Chicago, at The Four Seasons. MedCity INVEST is produced by MedCity News and MHIN (Mid-America Healthcare Investors Network).
For more information visit MedCity INVEST.
